A detailed history of Bryn Mawr Trust CO transactions in Zoetis Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 18,606 shares of ZTS stock, worth $3.06 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
18,606
Previous 2,065 801.02%
Holding current value
$3.06 Million
Previous $357,000 918.21%
% of portfolio
0.07%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

BUY
$172.58 - $196.48 $2.85 Million - $3.25 Million
16,541 Added 801.02%
18,606 $3.64 Million
Q1 2024

May 14, 2024

SELL
$165.67 - $199.94 $10,934 - $13,196
-66 Reduced 3.1%
2,065 $349,000
Q3 2023

Nov 15, 2023

BUY
$167.14 - $192.77 $145,411 - $167,709
870 Added 68.99%
2,131 $370,000
Q2 2023

Aug 11, 2023

BUY
$160.94 - $186.23 $202,945 - $234,836
1,261 New
1,261 $217,000
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $277,526 - $358,065
-1,530 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$193.69 - $247.03 $112,921 - $144,018
-583 Reduced 27.59%
1,530 $373,000
Q3 2021

Oct 26, 2021

SELL
$189.29 - $209.69 $10,978 - $12,162
-58 Reduced 2.67%
2,113 $410,000
Q2 2021

Jul 29, 2021

SELL
$155.9 - $187.99 $62,360 - $75,196
-400 Reduced 15.56%
2,171 $405,000
Q1 2021

Apr 23, 2021

SELL
$144.0 - $169.39 $7,920 - $9,316
-55 Reduced 2.09%
2,571 $405,000
Q4 2020

Feb 11, 2021

SELL
$157.07 - $174.35 $74,451 - $82,641
-474 Reduced 15.29%
2,626 $435,000
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $9,048 - $10,914
66 Added 2.18%
3,100 $513,000
Q2 2020

Aug 13, 2020

SELL
$111.92 - $142.53 $48,573 - $61,858
-434 Reduced 12.51%
3,034 $416,000
Q1 2020

May 08, 2020

BUY
$92.66 - $144.94 $172,162 - $269,298
1,858 Added 115.4%
3,468 $408,000
Q4 2019

Feb 11, 2020

BUY
$116.25 - $133.25 $187,162 - $214,532
1,610 New
1,610 $213,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.